General Information
Version
3
Revision date
2024-01-23
Product name
2-Fluoronitrobenzene
CAS No.
1493-27-2
Emergency telephone
001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Part of Thermo Fisher Scientific)
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H310, H315, H319, H373
Hazard statements
Code
Statements
H301
Toxic if swallowed
H310
Fatal in contact with skin
H315
Causes skin irritation
H319
Causes serious eye irritation
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
______________________________________________________________________________________________ ALFAAA13852 Page 1 / 11 Acute oral toxicity Category 3 (H301) Acute dermal toxicity Category 2 (H310) Skin Corrosion/Irritation Category 2 (H315) Serious Eye Damage/Eye Irritation Category 2 (H319) Specific target organ toxicity - (repeated exposure) Category 2 (H373)
Environmental hazards
Based on available data, the classification criteria are not met
Hazard statements
see section 16 H301 - Toxic if swallowed H310 - Fatal in contact with skin H315 - Causes skin irritation H319 - Causes serious eye irritation H373 - May cause damage to organs through prolonged or repeated exposure
Signal word
Danger
Precautionary statements
P310 - Immediately call a POISON CENTER or doctor/physician P302 + P352 - IF ON SKIN: Wash with plenty of soap and water P332 + P313 - If skin irritation occurs: Get medical advice/attention P280 - Wear protective gloves/protective clothing/eye protection/face protection
2.3 Other hazards
Substance is not considered persistent, bioaccumulative and toxic (PBT) / very persistent and very bioaccumulative (vPvB) This product does not contain any known or suspected endocrine disruptors